Effect of peptide to carrier ratio on the immune and ovarian response to inhibin immunization in cattle.
We report on the effects of the peptide to carrier ratio on the immune and biological response to inhibin immunization in cattle. A peptide sequence from the alpha C-subunit of bovine inhibin was synthesized and conjugated to human serum albumin (HSA) at ratios of 4.3 moles (L) and 13.1 moles (M) of peptide per mole of HSA. Hereford-cross heifers (n = 6 per group) were injected with 3 mg of one of the peptide conjugates at primary, followed by a booster injection (1.5 mg) 11 weeks later. Control heifers (n = 6) were injected with HSA only. Blood samples were taken at regular intervals to measure antibody titre. Ovulation rate was measured by ultrasonography. Antibodies were generated in both peptide immunized groups. Control heifers and group L heifers had 1 ovulation at all ovulatory cycles monitored. Ovulation rate was increased (P < 0.05) in group M immunized heifers, with four of six heifers having twin ovulations in the first cycle following boost. These data support those of previous studies which indicated that immunization against the alpha C-subunit of bovine inhibin significantly disrupted the mechanism(s) controlling ovulation rate in cattle. It also indicates that both the immune and associated biological response is dependent on the nature of the conjugate used for immunization, specifically the ratio of peptide to carrier.
Morris
D G
DG
Animal Reproduction Department, Agriculture and Food Development Authority, Tuam, Galway, Ireland. dmo@Belclare.Teagasc.ie
Browne
D
D
Diskin
M G
MG
Sreenan
J M
JM
D000818:Animals; D000906:Antibodies / Q000097:blood* / Q000276:immunology / Q000378:metabolism; D002352:Carrier Proteins / Q000032:analysis* / Q000276:immunology; D002417:Cattle / Q000097:blood / Q000276:immunology / Q000502:physiology*; D005260:Female; D006801:Humans; D007114:Immunization / Q000662:veterinary; D007265:Inhibins / Q000032:analysis / Q000276:immunology*; D007267:Injections / Q000662:veterinary; D010053:Ovary / Q000000981:diagnostic imaging / Q000502:physiology*; D010060:Ovulation / Q000502:physiology; D010455:Peptides / Q000032:analysis* / Q000276:immunology; D011897:Random Allocation; D012709:Serum Albumin / Q000276:immunology; D014427:Twins; D014463:Ultrasonography; D018074:Vaccines, Conjugate / Q000008:administration & dosage* / Q000737:chemistry / Q000276:immunology
D000906:Antibodies; D002352:Carrier Proteins; D010455:Peptides; D012709:Serum Albumin; D018074:Vaccines, Conjugate; D007265:Inhibins